Covidien, a global provider of healthcare products, today announced the discontinuation of its non-sterile alcohol prep pad product line sold under the brand names Webcol and Curity, effective Feb. 1, 2012. Covidien will continue to offer equivalent sterile products as a replacement for the discontinued non-sterile codes.Â
Covidien continues to maintain outstanding quality and process controls in our alcohol prep manufacturing processes, says Jim Clemmer, president of Covidien Medical Supplies. The recent discovery of Bacillus cereus in other manufacturers products, however, has led us to re-evaluate our non-sterile portfolio. In an effort to reassure our customers and reduce any risk to patients, we have made the decision to discontinue these products.
Covidien has never recalled alcohol prep pads. The company produces more than 1 billion Webcol and Curity alcohol preps each year at its facility in Augusta, Ga. Covidien is focused on innovative manufacturing processes and rigorous quality standards, which result in a consistently reliable product. Over 10 different inspections, tests and quality controls are applied to each production lot.Â
While an alcohol prep pad may seem like a small item in the medical supplies portfolio, it does have direct patient contact and direct patient consequences, Clemmer adds. With our alcohol preps our customers know the manufacturer and trust the brand. Covidien wound care products represent over a century of quality and innovation trusted by healthcare professionals around the world.
Tackling Health Care-Associated Infections: SHEA’s Bold 10-Year Research Plan to Save Lives
December 12th 2024Discover SHEA's visionary 10-year plan to reduce HAIs by advancing infection prevention strategies, understanding transmission, and improving diagnostic practices for better patient outcomes.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
The Importance of Hand Hygiene in Clostridioides difficile Reduction
November 18th 2024Clostridioides difficile infections burden US healthcare. Electronic Hand Hygiene Monitoring (EHHMS) systems remind for soap and water. This study evaluates EHHMS effectiveness by comparing C difficile cases in 10 hospitals with CMS data, linking EHHMS use to reduced cases.